Table 1.
Baseline characteristics.
| Variables | MAFLD (n = 24,283) | Without MAFLD (47,016) | P-value |
|---|---|---|---|
| Age | 49 (38, 56) | 41 (32, 52) | P < 0.001 |
| AST/ALT | 0.83 (0.66, 1.03) | 1.17 (0.93, 1.44) | P < 0.001 |
| ALT | 29.20 (20.70, 43.00) | 17.5 (13.00, 24.80) | P < 0.001 |
| GGT | 35.30 (23.30, 58.00) | 17.3 (12.7, 26.6) | P < 0.001 |
| LDL-C | 3.33 (2.81, 3.85) | 2.98 (2.51, 3.50) | P < 0.001 |
| AST | 24.20 (20.10, 30.30) | 20.60 (17.50, 24.70) | P < 0.001 |
| TC | 5.23 (4.59, 5.92) | 4.89 (4.30, 5.55) | P < 0.001 |
| HDL-C | 1.24 (1.08, 1.43) | 1.50 (1.29, 1.74) | P < 0.001 |
| FPG | 5.30 (4.89, 5.95) | 4.89 (4.59, 5.22) | P < 0.001 |
| TG | 173.55 (122.19, 253.24) | 92.97 (69.07, 129.28) | P < 0.001 |
| WHR | 0.91 (0.88, 0.95) | 0.83 (0.78, 0.88) | P < 0.001 |
| SBP | 127 (117, 137) | 115 (105, 126) | P < 0.001 |
| DBP | 78 (70, 85) | 70 (64, 77) | P < 0.001 |
| WC | 90 (85, 96) | 77 (71, 83) | P < 0.001 |
| BMI | 26.59 (24.92, 28.55) | 22.36 (20.62, 24.17) | P < 0.001 |
| TyG | 6.17 (5.79, 6.59) | 5.43 (5.11, 5.80) | P < 0.001 |
| TyG-WC | 558.26 (508.94, 614.99) | 418.15 (369.91, 473.25) | P < 0.001 |
| TyG-BMI | 164.82 (149.79, 182.71) | 121.79 (107.57, 137.40) | P < 0.001 |
| TyG-WHR | 5.63 (5.18, 6.15) | 4.50 (4.07, 4.99) | P < 0.001 |
| History of hypertension | P < 0.001 | ||
| No | 16,027 (66.00%) | 41,278 (87.80%) | |
| Yes | 8256 (34.00%) | 5738 (12.20%) | |
| History of diabetes | P < 0.001 | ||
| No | 21,257 (87.53%) | 45,959 (97.75%) | |
| Yes | 3026 (12.46%) | 1057 (2.25%) | |
| Sex | P < 0.001 | ||
| Males | 17,487 (72.01%) | 19,847 (42.21%) | |
| Females | 6796 (27.99%) | 27,169 (57.79%) | |
Continuous variables are presented as median with the IQR (M (P25, P75)).
Categorical variables are presented as frequencies (percentages).
ALT alanine aminotransferase, AST aspartate transaminase, BMI body mass index, DBP diastolic blood pressure, FPG fasting plasma glucose, GGT gamma-glutamyltransferase, HDL high-density lipoprotein, SBP systolic blood pressure, TC total cholesterol, TG serum triglyceride, TyG triglyceride–glucose, TyG-BMI triglyceride–glucose body mass index, TyG-WC triglyceride–glucose waist circumference, TyG-WHR triglyceride–glucose waist-to-hip ratio, WC waist circumference, WHR waist-to-hip ratio.